453 related articles for article (PubMed ID: 16600737)
1. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
[TBL] [Abstract][Full Text] [Related]
2. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
[TBL] [Abstract][Full Text] [Related]
3. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
4. Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion.
Thomas E; von Unruh GE; Hesse A
Eur J Clin Nutr; 2008 Sep; 62(9):1090-7. PubMed ID: 17609696
[TBL] [Abstract][Full Text] [Related]
5. Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.
von Unruh GE; Voss S; Sauerbruch T; Hesse A
J Urol; 2003 Feb; 169(2):687-90. PubMed ID: 12544343
[TBL] [Abstract][Full Text] [Related]
6. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
8. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
9. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
Oehlschläger S; Fuessel S; Meye A; Herrmann J; Froehner M; Albrecht S; Wirth MP
Urology; 2009 Mar; 73(3):480-3. PubMed ID: 19167040
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans--preliminary results in patients with idiopathic calcium urolithiasis.
Herrmann U; Schwille PO; Schmiedl A; Fan J; Manoharan M
Biomed Pharmacother; 1999 Jun; 53(5-6):264-73. PubMed ID: 10424248
[TBL] [Abstract][Full Text] [Related]
12. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
[TBL] [Abstract][Full Text] [Related]
13. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
[TBL] [Abstract][Full Text] [Related]
14. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
15. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
16. [Oxalate loading test for outpatients with calcium oxalate stones].
Kato M
Hinyokika Kiyo; 1986 Mar; 32(3):351-60. PubMed ID: 3728240
[TBL] [Abstract][Full Text] [Related]
17. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
18. The role of overweight and obesity in calcium oxalate stone formation.
Siener R; Glatz S; Nicolay C; Hesse A
Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
[TBL] [Abstract][Full Text] [Related]
19. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
Osther PJ
Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
[TBL] [Abstract][Full Text] [Related]
20. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.
Sikora P; von Unruh GE; Beck B; Feldkötter M; Zajaczkowska M; Hesse A; Hoppe B
Kidney Int; 2008 May; 73(10):1181-6. PubMed ID: 18337715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
